Contact this trialFirst, we need to learn more about you.
Virus Therapy
Zimberelimab for Solid Cancers
Recruiting1 awardPhase 1
Seattle, Washington
This trial tests a new drug, GS-4528, alone or with an immune therapy in people with advanced solid tumors. The goal is to see if it is safe and to find the best dose. The combination aims to help the immune system fight cancer more effectively.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service